Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil A Zakai

Showing results (41-50 of 163) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 2, 2021
Television viewing, physical activity and venous thromboembolism risk: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) StudyJordan A Munger, Insu Koh, George Howard, et al.
Research and Practice in Thrombosis and Haemostasis|May 27, 2024
Bleeding risk from anticoagulant thromboprophylaxis in patients with multiple myeloma: a MarketScan analysisDiego Adrianzen-Herrera, Katherine Giorgio, Rob F Walker, et al.
Case Reports in Medicine|October 18, 2016
Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the LiteratureJavier De Luca-Johnson, Jose I Ruades Ninfea, Lauren Pearson, et al.
American Journal of Hematology|October 10, 2012
Hemoglobin decline, function, and mortality in the elderly: the cardiovascular health studyNeil A Zakai, Benjamin French, Alice M Arnold, et al.
Journal of the American Heart Association|October 8, 2021
Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018Pamela L Lutsey, Rob F Walker, Richard F MacLehose, et al.
Plos One|March 13, 2018
Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohortKristine S Alexander, Neil A Zakai, Steven D Lidofsky, et al.
Circulation|February 11, 2014
Racial and regional differences in venous thromboembolism in the United States in 3 cohortsNeil A Zakai, Leslie A McClure, Suzanne E Judd, et al.
JAMA Internal Medicine|November 12, 2019
Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without HypogonadismRob F Walker, Neil A Zakai, Richard F MacLehose, et al.
Vascular Medicine (London, England)|July 28, 2020
Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolismPamela L Lutsey, Richard F MacLehose, J'Neka S Claxton, et al.
Journal of the American Heart Association|September 13, 2021
Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous ThromboembolismAlvaro Alonso, Faye L Norby, Richard F MacLehose, et al.
Pageof 17

Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Haemostasis : JTH|June 2, 2021
Television viewing, physical activity and venous thromboembolism risk: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) StudyJordan A Munger, Insu Koh, George Howard, et al.
Research and Practice in Thrombosis and Haemostasis|May 27, 2024
Bleeding risk from anticoagulant thromboprophylaxis in patients with multiple myeloma: a MarketScan analysisDiego Adrianzen-Herrera, Katherine Giorgio, Rob F Walker, et al.
Case Reports in Medicine|October 18, 2016
Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the LiteratureJavier De Luca-Johnson, Jose I Ruades Ninfea, Lauren Pearson, et al.
American Journal of Hematology|October 10, 2012
Hemoglobin decline, function, and mortality in the elderly: the cardiovascular health studyNeil A Zakai, Benjamin French, Alice M Arnold, et al.
Journal of the American Heart Association|October 8, 2021
Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018Pamela L Lutsey, Rob F Walker, Richard F MacLehose, et al.
Plos One|March 13, 2018
Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohortKristine S Alexander, Neil A Zakai, Steven D Lidofsky, et al.
Circulation|February 11, 2014
Racial and regional differences in venous thromboembolism in the United States in 3 cohortsNeil A Zakai, Leslie A McClure, Suzanne E Judd, et al.
JAMA Internal Medicine|November 12, 2019
Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without HypogonadismRob F Walker, Neil A Zakai, Richard F MacLehose, et al.
Vascular Medicine (London, England)|July 28, 2020
Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolismPamela L Lutsey, Richard F MacLehose, J'Neka S Claxton, et al.
Journal of the American Heart Association|September 13, 2021
Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous ThromboembolismAlvaro Alonso, Faye L Norby, Richard F MacLehose, et al.
Pageof 17